Back to Browse Journals » Degenerative Neurological and Neuromuscular Disease » Volume 2

Pathogenic mechanisms of neurodegeneration based on the phenotypic expression of progressive forms of immune-mediated neurologic disease

Authors Levin MC, Lee S, Gardner LA, Shin Y, Douglas JN, Groover CJ

Published Date December 2012 Volume 2012:2 Pages 175—187

DOI http://dx.doi.org/10.2147/DNND.S38353

Received 20 September 2012, Accepted 30 October 2012, Published 5 December 2012

Michael C Levin,1–3 Sangmin Lee,1,2 Lidia A Gardner,1,2 Yoojin Shin,1,2 Joshua N Douglas,1,3 Chassidy J Groover1,2

1Veterans Administration Medical Center, Memphis, TN, USA; 2Departments of Neurology, 3Neuroscience, University of Tennessee Health Science Center, Memphis, TN, USA

Abstract: Considering there are no treatments for progressive forms of multiple sclerosis (MS), a comprehensive understanding of the role of neurodegeneration in the pathogenesis of MS should lead to novel therapeutic strategies to treat it. Many studies have implicated viral triggers as a cause of MS, yet no single virus has been exclusively shown to cause MS. Given this, human and animal viral models of MS are used to study its pathogenesis. One example is human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Importantly, HAM/TSP is similar clinically, pathologically, and immunologically to progressive MS. Interestingly, both MS and HAM/TSP patients were found to make antibodies to heterogeneous nuclear ribonucleoprotein (hnRNP) A1, an RNA-binding protein overexpressed in neurons. Anti-hnRNP A1 antibodies reduced neuronal firing and caused neurodegeneration in neuronal cell lines, suggesting the autoantibodies are pathogenic. Further, microarray analyses of neurons exposed to anti-hnRNP A1 antibodies revealed novel pathways of neurodegeneration related to alterations of RNA levels of the spinal paraplegia genes (SPGs). Mutations in SPGs cause hereditary spastic paraparesis, genetic disorders clinically indistinguishable from progressive MS and HAM/TSP. Thus, there is a strong association between involvement of SPGs in neurodegeneration and the clinical phenotype of progressive MS and HAM/TSP patients, who commonly develop spastic paraparesis. Taken together, these data begin to clarify mechanisms of neurodegeneration related to the clinical presentation of patients with chronic immune-mediated neurological disease of the central nervous system, which will give insights into the design of novel therapies to treat these neurological diseases.

Keywords: human T-lymphotropic virus type 1 (HTLV-1), multiple sclerosis, neurodegeneration, heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1), autoimmunity, spastic paraparesis, RNA-binding protein

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

Neurodegeneration in multiple sclerosis involves multiple pathogenic mechanisms

Levin MC, Douglas JN, Meyers L, Lee S, Shin Y, Gardner LA

Degenerative Neurological and Neuromuscular Disease 2014, 4:49-63

Published Date: 12 March 2014

Readers of this article also read:

Comparison study of ferrofluid and powder iron oxide nanoparticle permeability across the blood–brain barrier

Hoff D, Sheikh L, Bhattacharya S, Nayar S, Webster TJ

International Journal of Nanomedicine 2013, 8:703-710

Published Date: 13 February 2013

Comparative digital cartilage histology for human and common osteoarthritis models

Pedersen DR, Goetz JE, Kurriger GL, Martin JA

Orthopedic Research and Reviews 2013, 5:13-20

Published Date: 12 February 2013

Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study

Cotroneo AM, Castagna A, Putignano S, Lacava R, Fantò F, Monteleone F, Rocca F, Malara A, Gareri P

Clinical Interventions in Aging 2013, 8:131-137

Published Date: 5 February 2013

Comparison of two treatments for coxarthrosis: local hyperthermia versus radio electric asymmetrical brain stimulation

Castagna A, Rinaldi S, Fontani V, Mannu P, Lotti Margotti M

Clinical Interventions in Aging 2011, 6:201-206

Published Date: 25 July 2011

DataGenno: building a new tool to bridge molecular and clinical genetics

Fabricio F Costa, Luciano S Foly, Marcelo P Coutinho

The Application of Clinical Genetics 2011, 4:45-54

Published Date: 18 March 2011

Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity

Joseph Finkelstein, Eunme Cha, Steven M Scharf

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:337-349

Published Date: 4 September 2009

China’s role in global competition in the wine industry: A new contestant and future trends

Darryl J Mitry, David E Smith, Per V Jenster

International Journal of Wine Research 2009, 1:19-25

Published Date: 21 January 2009